ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $220,870 | -12.7% | 4,788 | -21.8% | 0.01% | +55.6% |
| Q3 2022 | $253,000 | +9.1% | 6,119 | +121.8% | 0.01% | +50.0% |
| Q4 2021 | $232,000 | -37.1% | 2,759 | -28.7% | 0.01% | -45.5% |
| Q2 2021 | $369,000 | +63.3% | 3,869 | +94.9% | 0.01% | +83.3% |
| Q1 2021 | $226,000 | +247.7% | 1,985 | +150.0% | 0.01% | +100.0% |
| Q3 2020 | $65,000 | -90.0% | 794 | -90.5% | 0.00% | -91.7% |
| Q2 2020 | $651,000 | +425.0% | 8,322 | +197.2% | 0.04% | +350.0% |
| Q1 2020 | $124,000 | +1277.8% | 2,800 | +2070.5% | 0.01% | +700.0% |
| Q1 2019 | $9,000 | -98.2% | 129 | -98.4% | 0.00% | -97.9% |
| Q2 2017 | $497,000 | +163.0% | 8,000 | +167.3% | 0.05% | +80.8% |
| Q1 2016 | $189,000 | – | 2,993 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |